🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCompounding & FormulationBacteriostatic water sourcing and sterility considerations

Bacteriostatic water sourcing and sterility considerations

SarahChen_PharmD Sun, Jun 7, 2026 at 5:41 PM 8 replies 114 viewsPage 1 of 2
SarahChen_PharmD
VIP Member
4,567
22,341
Dec 2023
San Diego, CA
Jun 7, 2026 at 5:41 PM#1

This is the version of the explanation I wish somebody had given me, written down before I forget what confused me. It is about the dosing arithmetic, and it is deliberately narrow — everything I am not confident about is marked as such.

What is actually established

Dead space is the answer to the missing dose. A fixed-needle insulin syringe holds a few microlitres in the hub and needle after the plunger bottoms out, and on small draws that is a measurable percentage of every dose. Across ten draws it adds up to most of an eleventh, which is exactly the "nine draws from a ten-dose vial" complaint. Luer-lock syringes are worse; low-dead-space fixed-needle designs are better.

The condition it depends on

It is worth saying that rounding to the nearest whole unit is usually acceptable at maintenance doses and is not acceptable at the bottom of a ladder, where one unit can be a fifth of the intended dose.

The practical version

The three numbers to write on the vial: total mg, total ml, and mg per ml. Everything else is division. And the sanity check is that dose volume times number of doses should be less than the volume you put in, because dead space takes the difference.

What I am not sure about

The question I want answered is how much material I am losing to dead space, and whether that explains why a 10mg vial gives me nine usable draws rather than ten. Numbers rather than impressions, if you have them.

— SarahChen_PharmD · corrections welcome and will be edited into this post with credit
10 5Dr.ObesityLA, NurseKim_ATL, paul_denver and 7 others
Reply Quote Save Share Report
PurityPaulOR
Senior Member
1,890
7,890
Mar 2024
Oregon
Jun 7, 2026 at 5:49 PM#2
SarahChen_PharmD said:
Dead space is the answer to the missing dose.

That is correct as far as it goes, and here is where it stops going. Do it in two steps and it stops being confusing. First concentration: 10mg into 2ml is 5mg/ml. Then volume: a 0.5mg dose is 0.5 ÷ 5 = 0.1ml. Then units, and this is where people go wrong — a U-100 syringe is graduated in hundredths of a millilitre, so 0.1ml is 10 units. The word "units" has nothing to do with milligrams; it is a volume marking that exists because insulin happens to come at 100 units per ml.

9 4MikeNYC_runner and 6 others
Reply Quote Save Share Report
DataDave
Senior Member
1,678
8,901
Apr 2024
Washington
Online
Jun 7, 2026 at 5:57 PM#3
SarahChen_PharmD said:
Dead space is the answer to the missing dose.

I am going to disagree with reconstituting low as a general rule. More diluent, more punctures, more in-use days at room temperature, and the stability trade-off is real. Precision is not the only variable being optimised.

If somebody has the primary source to hand I would rather cite it than paraphrase it.

8 3LondonLisa, mike_nyc, VendorMark and 5 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
anna.melb_AU
Member
678
2,890
Apr 2024
Melbourne, AU
Jun 7, 2026 at 6:05 PM#4

Short answer first, then the reasoning. Concentration choice is a precision decision, not a preference. Reconstitute high and every dose is a tiny volume where one unit of syringe error is a large fraction of the dose. Reconstitute low and you get more graduations per dose, so the same hand tremor costs proportionally less. Against that, more diluent means more benzyl alcohol and a shorter comfortable in-use window.

If somebody has the primary source to hand I would rather cite it than paraphrase it.

7 2tammy_FL, Dr.LipidDallas, alex_tucson and 4 others
Reply Quote Save Share Report
maria_elpaso
Member
312
1,456
Sep 2024
El Paso, TX
Jun 7, 2026 at 6:45 PM#5
PurityPaulOR said:
Do it in two steps and it stops being confusing.

Agreed, with a caveat about community reputation: it is a lagging indicator. Reports arrive weeks after orders, so a supplier can look excellent for a month after quality has already changed.

6 1LibrarianMeg, bri_stats, pete_manc_UK and 3 others
Reply Quote Save Share Report

Similar Threads

503A vs 503B compounding — regulatory framework explained4 replies
Compounded semaglutide stability: accelerated degradation study results6 replies
Lyophilized vs liquid peptides — stability and bioavailability comparison18 replies
State-by-state compounding pharmacy regulations — 2026 map8 replies
Beyond-use dating for compounded peptides — USP <797> compliance6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register